Compare SOPH & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | FEIM |
|---|---|---|
| Founded | 2011 | 1961 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 439.6M |
| IPO Year | 2021 | 1994 |
| Metric | SOPH | FEIM |
|---|---|---|
| Price | $5.38 | $65.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.50 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 333.8K | 189.6K |
| Earning Date | 05-05-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 316.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $69,811,000.00 |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | $21.73 |
| P/E Ratio | ★ N/A | $157.54 |
| Revenue Growth | N/A | ★ 26.30 |
| 52 Week Low | $2.83 | $18.70 |
| 52 Week High | $6.30 | $80.00 |
| Indicator | SOPH | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 46.56 |
| Support Level | $4.59 | $62.33 |
| Resistance Level | $5.65 | $78.04 |
| Average True Range (ATR) | 0.40 | 5.63 |
| MACD | 0.02 | -1.09 |
| Stochastic Oscillator | 36.24 | 22.95 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.